Keywords
How to Cite
Abstract
Introduction: Identifying factors that are associated of allograft function loss might be an important step toward prolonging kidney allograft survival.
Purpose: In this study we found to determine the association between histologic changes on 1-year surveillance biopsies and changes in graft function.
Methods: Recipients of kidneys from deceased donors (95%) or living donors (5%) trasplanted between 2007 and 2012. The primary end point was reduction in calculated glomerular filtration rate (Cockroft anf Gault) higher 5ml/min 12 months post transplant vs calculated glomerular filtration rate previous surveillance biopsie.
Results: This analysis included 114 adults, recipients of kidneys with low immunological risk receiving basiliximab induction from deceased donors (95%) or living donors (5%), transplanted between august 2007 and july 2012. The primary end point was reduction in calculated glomerular filtration rate (Cockroft & Gault) higher 5ml/min 12 months post trasplant . 25 of 114 patientes showing reduction; The histologic changes associated with renal function reduction were glomerulitis (p=0,024), interstitial inflamation (p=0,001), tubulitis (p=0,001), capilaritis (p=0,001), glomerulitis + capilaritis (p=0,001), polyoma virus nephropathy (p=0,04) and subclinical rejection (p=0,015). By regression analyses, interstitial inflamation (OR = 2,11; IC 95%: 1,13-3,95) and capilaritis (0R=7,12; IC 95%:1,57-32,27) were associated with renal function redcution 12 month post-transplant.
Conclusion: inflammation and capilaritis in protocol biopsies in first year post-transplant predict loss of graft function and independently of other variables.
References
Ramos E, Aoun S, Harmon WE. Expanding the donor pool: effect on graft outcome. J Am Soc Nephrol. 2002;13(10):2590-9.
Marsden PA. Predicting outcomes after renal transplantation—new tools and old tools. N Engl J Med. 2003;349(2):182-4. https://doi.org/10.1056/NEJMe030096
Ponticelli C. Renal transplantation 2004: where do we stand today? Nephrol Dial Transplant. 2004;19(12):2937-47. https://doi.org/10.1093/ndt/gfh511
Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int. 2002;62(1):311-8. https://doi.org/10.1046/j.1523-1755.2002.00424.x
Cosio FG, Grande JP, Wadei H, Larson TS, Griffin MD, Stegall MD. Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant. 2005;5(10):2464-72. https://doi.org/10.1111/j.1600-6143.2005.01050.x
Nankivell BJ, Fenton-Lee CA, Kuypers DR, Cheung E, Allen RD, O’Connell PJ, et al. Effect of histological damage on long-term kidney transplant outcome. Transplantation. 2001;71(4):515-23.
de Freitas DG, Sellarés J, Mengel M, Chang J, Hidalgo LG, Famulski KS, et al. The nature of biopsies with «borderline rejection» and prospects for eliminating this category. Am J Transplant. 2012;12(1):191-201. https://doi.org/10.1111/j.1600-6143.2011.03784.x
Nankivell BJ, Borrows RJ, Fung CL, O’Connell PJ, Allen RD, Chapman JR. Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation. 2004;78(2):242-9.
Gloor JM, Cohen AJ, Lager DJ, Grande JP, Fidler ME, Velosa JA, et al. Subclinical rejection in tacrolimus-treated renal transplant recipients. Transplantation. 2002;73(12):1965-8.
Rush D, Arlen D, Boucher A, Busque S, Cockfield SM, Girardin C, et al. Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized study. Am J Transplant. 2007;7(11):2538-45. https://doi.org/10.1111/j.1600-6143.2007.01979.x
Rowshani AT, Scholten EM, Bemelman F, Eikmans M, Idu M, Roos-van Groningen MC, et al. No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year. J Am Soc Nephrol. 2006;17(1):305-12. https://doi.org/10.1681/ASN.2005030249
Nankivell BJ, Borrows RJ, Fung CL, O’Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med. 2003;349(24):2326-33. https://doi.org/10.1056/NEJMoa020009
Ibernón M, Gomá M, Moreso F, Fulladosa X, Hueso M, Cruzado JM, et al. Subclinical rejection impairs glomerular adaptation after renal transplantation. Kidney Int. 2006;70(3):557-61. https://doi.org/ https://doi.org/10.1038/sj.ki.5001582
Mengel M, Gwinner W, Schwarz A, Bajeski R, Franz I, Bröcker V, et al. Infiltrates in protocol biopsies from renal allografts. Am J Transplant. 2007;7(2):356-65.
Roberts IS, Reddy S, Russell C, Davies DR, Friend PJ, Handa AI, et al. Subclinical rejection and borderline changes in early protocol biopsy specimens after renal transplantation. Transplantation. 2004;77(8):1194-8.
Rush D, Nickerson P, Gough J, McKenna R, Grimm P, Cheang M, et al. Beneficial effects of treatment of early subclinical rejection: a randomized study. J Am Soc Nephrol. 1998;9(11):2129-34.
Rush D. Protocol transplant biopsies: an underutilized tool in kidney transplantation. Clin J Am Soc Nephrol. 2006;1(1):138-43. https://doi.org/10.2215/CJN.00390705
Papadimitriou JC, Drachenberg CB, Munivenkatappa R, Ramos E, Nogueira J, Sailey C, et al. Glomerular inflammation in renal allografts biopsies after the first year: cell types and relationship with antibody-mediated rejection and graft outcome. Transplantation. 2010;90(12):1478-85. https://doi.org/10.1097/TP.0b013e3181ff87f5
Batal I, Lunz JG, Aggarwal N, Zeevi A, Sasatomi E, Basu A, et al. A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies. Am J Transplant. 2010;10(11):2442-52. https://doi.org/10.1111/j.1600-6143.2010.03261.x
Gibson IW, Gwinner W, Bröcker V, Sis B, Riopel J, Roberts IS, et al. Peritubular capillaritis in renal allografts: prevalence, scoring system, reproducibility and clinicopathological correlates. Am J Transplant. 2008;8(4):819-25. https://doi.org/10.1111/j.1600-6143.2007.02137
Lerut E, Naesens M, Kuypers DR, Vanrenterghem Y, Van Damme B. Subclinical peritubular capillaritis at 3 months is associated with chronic rejection at 1 year. Transplantation. 2007;83(11):1416-22. https://doi.org/ 10.1097/01.tp.0000266676.10550.70
Lipták P, Kemény E, Morvay Z, Szederkényi E, Szenohradszky P, Marofka F, et al. Peritubular capillary damage in acute humoral rejection: an ultrastructural study on human renal allografts. Am J Transplant. 2005;5(12):2870-6. https://doi.org/10.1111/j.1600-6143.2005.01102.x
Loupy A, Suberbielle-Boissel C, Hill GS, Lefaucheur C, Anglicheau D, Zuber J, et al. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant. 2009;9(11):2561-70. https://doi.org/10.1111/j.1600-6143.2009.02813.x
Husain S, Sis B. Advances in the understanding of transplant glomerulopathy. Am J Kidney Dis. 2013;62(2):352-63. https://doi.org/10.1053/j.ajkd.2012.10.026